We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Netscientific Plc | LSE:NSCI | London | Ordinary Share | GB00BN4R5Q82 | ORD 5P |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 0.00 | 0.00% | 53.50 | 0.00 | 00:00:00 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 53.00 | 54.00 | ||||
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 1.45M | -2.64M | -0.1104 | -4.85 | 12.81M |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| - | O | 0 | 53.50 | GBX |
| Date | Time | Source | Headline |
|---|---|---|---|
| 16/9/2024 | 13:31 | UK RNS | NetScientific PLC PDS: Updated Results, VERSATILE-002 Phase 2 Trial |
| 16/8/2024 | 19:40 | ALNC |  TRADING UPDATES: NetScientific loss narrows; Vinanz ups Bitcoin fleet |
| 13/8/2024 | 14:57 | UK RNS | NetScientific PLC PDS Biotech: Business Update and Q2 2024 Results |
| 02/8/2024 | 11:21 | UK RNS | NetScientific PLC Replacement RNS: PDS Biotech Aligns with FDA |
| 02/8/2024 | 06:00 | UK RNS | NetScientific PLC PDS Biotech Aligns with FDA on Phase 3 Trial |
| 30/7/2024 | 06:00 | UK RNS | NetScientific PLC Q-Bot Fundraising |
| 10/7/2024 | 09:48 | UK RNS | NetScientific PLC Result of AGM |
| 18/6/2024 | 06:00 | UK RNS | NetScientific PLC Notice of AGM |
| 14/6/2024 | 13:10 | UK RNS | NetScientific PLC TR-1 |
| 14/6/2024 | 06:00 | UK RNS | NetScientific PLC Director/PDMR Shareholding |
Netscientific (NSCI) Share Charts1 Year Netscientific Chart |
|
1 Month Netscientific Chart |
Intraday Netscientific Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 26/9/2024 | 07:01 | NetScientific PLC | 5,982 |
| 24/1/2021 | 19:11 | NETSCIENTIFIC | 10 |
| 15/6/2019 | 10:31 | Netscientific | 16 |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|
| Top Posts |
|---|
Posted at 14/12/2024 08:20 by Netscientific Daily Update Netscientific Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker NSCI. The last closing price for Netscientific was 53.50p.Netscientific currently has 23,945,828 shares in issue. The market capitalisation of Netscientific is £12,811,018. Netscientific has a price to earnings ratio (PE ratio) of -4.85. This morning NSCI shares opened at - |
Posted at 24/9/2024 21:26 by btgman Interesting comments around £2 NAV. This is really interesting down here share price has now dismissed the recent Martlet Capital deal along with some fairly significant updates from several of the portfolio.Yes £2 NAV all day long but that is hardly the story. Glycotest looks absolutely incredible within 2 years Glycotest will be worth significantly more than £2 to NSCI on its own. We have a several high upside assets in our portfolio so for me £2 isn't the number. More likely multiples of £2 AIMHO GLA BTG |
Posted at 23/9/2024 15:09 by loafofbread Some decent news out from Glycotest today. Looks like it might be worth multiple millions rather than the zero value that the NSCI share price gives it! |
Posted at 23/8/2024 09:56 by kingston78 It has looked to me for quite some time that the share price will drift to the 50 p level again. If it does, I think that should be the bottom. It may crawl along and bounce up from there. A double bottom (excuse me for the language)in charting term is good for a bounce.The trading volume is low, indicating lack of interest by both existing and new shareholders. In this regard, the company's PR is dreadful. NSCI is simply an investment company without deep pocket. It should have sold its stake in PDSB long ago when PDSB's share price was above US$14 a share but it is trading at US$3 to US$4. You cannot rely on one investment as being the "wonder stock" when it gets less appealing (with benefit of hindsight). As investors, we buy, sell or hold, and we probably take all those actions. NSCI only buys and holds, and wait for its investments to become more valuable. NSCI does not sell when its investments become more valuable (maybe getting greedy). That is a poor investor's attitude. A paper profit is not a profit until realised. This is basic investment rule. I should teach the directors some basic investment rules. |
Posted at 18/7/2024 07:52 by kingston78 This morning IUG has announced the sale of one of its businesses for £40.5 million, and its share price has gone up by 82%. Yet even at the latest higher share price it is capitalised at £38 million, which is less than the sale price of its subsidiary.Anyway, an 82% uplift of the share price is nonetheless extremely welcome to shareholders. Why can't something like this happen to NSCI? Should I propose myself to join the board as a director to get the right connection for them? |
Posted at 06/7/2024 23:17 by kingston78 My previous summary that the company was trading at the top of its band at 79 p has been proven correct. The share price has since dropped back to 70-72 p.A wife was complaining to her friends that whilst her husband's business was doing well she did not see any improvement in their standard of living. Some years later when her husband cashed in his business they suddenly became cash millionaires. NSCI (or rather us investors)is like the wife described above. Asset rich but cash poor. Dragon's Den will ask a simple question, "show me the cash". Value may rise and value may fall. Only cash is king. As reiterated before, NSCI will only rise substantially if a large investor continues to buy its shares to push up the price, or a large profitable cash exit from one or more of its investments will pave the way upwards. Small investors have little influence. |
Posted at 26/6/2024 17:17 by kingston78 NSCI is always lightly traded, so there cannot be many followers or new investors. I think that there is a lack of promotion to the right audience.Despite MM has marked down the price by 1p today the spread has narrowed from 6p to only 1 p (72-73p). It would appear that MM wants sellers to sell them the stock, as they keep a tight book. In this respect, any pent up demand generated by, for example, an investment recommendation by IC or others, will raise the share price by a few pence. Anyway, as I have iterated before, unless and until the company has realised real cash in exiting one or more of its investments the share price will reach 90 p - 100 p at best in the next few months. If achieved, that is not a bad return. Years ago, I realised that investment trusts were mostly trading at a discount to their underlying assets whilst Unit Trusts were trading at a premium. This is a perception issue. NSCI is acting like an investment trust, investing in a number of companies that may generate a good return. I have no doubt in my mind that one day, we only need a blockbuster to increase the value of NSCI many folds. We live in hope. |
Posted at 13/6/2024 10:18 by kingston78 The important factor was that when PDSB was at a high of US$14 the share price of NSCI had hardly progressed. Subsequent events have shown that NSCI has become a more rounded investment companies with a promising portfolio of high tech companies at their early stage. Moreover, NSCI does not contribute much in cash term the advancement of those companies, which rely on external funding, which at a higher subscription price, actually adds value to NSCI despite the fact that they are unlisted. One of these days there will be a profitable exit, or exits, and investors will see that NSCI has many gems. This is akin to some people who are asset rich but cash poor.I am just concerned that NSCI will not have sufficient cash to run its corporate activities and resort to a discounted fund raising itself. |
Posted at 01/5/2024 15:20 by loafofbread Looking at IP GROUP discount to NAV.They have gone down the share buy back route which is 100% where NSCI should be looking to close the gap between the 60p share price and the £2.00 NAV. Why invest money elsewhere when you can effectively buy assets at a 200% discount! Continued commitment to shareholder returns - Launched further £20m share buyback fulfilling our commitment to regular cash returns from realisations - As announced on 18 December 2023, future cash returns are expected to be in the form of share buybacks when the share price discount to NAV exceeds 20% |
Posted at 17/11/2023 08:17 by loafofbread Much easier if they just posted a normal spread on NSCI.Another £500K increase in PDSB. NSCI share price is so far behind fair value it's unreal. |
Posted at 31/5/2023 15:57 by blakieboy7 PDSB now up over 9 dollars, not that it's making FA difference to NSCI share price!! That's over 5.5% up so far |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
